Amanote Research

Amanote Research

    RegisterSign In

New Zealand's Review of the Psychoactive Substances Act 2013: A Missed Learning Opportunity Ahead of the National Cannabis Law Reform Referendum?

Addiction - United Kingdom
doi 10.1111/add.14589
Full Text
Open PDF
Abstract

Available in full text

Categories
MedicinePsychiatryMental Health
Date

March 20, 2019

Authors
Marta RychertChris Wilkins
Publisher

Wiley


Related search

New Psychoactive Substances in Ireland Following the Criminal Justice (Psychoactive Substances) Act-Why All the Pessimism?

Addiction
MedicinePsychiatryMental Health
2017English

Inconsistencies in the Assumptions Linking Punitive Sanctions and Use of Cannabis and New Psychoactive Substances in Europe

Addiction
MedicinePsychiatryMental Health
2018English

Acheson: A Missed Opportunity for the New Public Health

BMJ
1988English

Acheson: A Missed Opportunity for the New Public Health

BMJ
1988English

Acheson: A Missed Opportunity for the New Public Health

BMJ
1988English

Acheson: A Missed Opportunity for the New Public Health

BMJ
1988English

Assessing the ‘Added Value’ of European Policy on New Psychoactive Substances

International Journal of Drug Policy
MedicineHealth Policy
2017English

Methylone and Pentylone: Structural Analysis of New Psychoactive Substances

Forensic Toxicology
BiochemistryForensic MedicinePathologyToxicology
2019English

The Emergence of New Psychoactive Substance (NPS) Benzodiazepines: A Review

Drug Testing and Analysis
Environmental ChemistryAnalytical ChemistrySpectroscopyPharmaceutical Science
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy